Blog & News Articles

Gail Lynn Wright, MD Co-Authors Phase II Study Examining Trilaciclib in Treatment of Metastatic Triple-Negative Breast Cancer

Ivor Percent, MD, Maen Hussein, MD, and Viralkumar Bhanderi, MD